Type 2 immunity: a two-edged sword in schistosomiasis immunopathology
- 12 July 2022
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 43 (8) , 657-673
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation
This publication has 98 references indexed in Scilit:
- Interleukin-4- and Interleukin-13-Mediated Alternatively Activated Macrophages: Roles in Homeostasis and DiseaseAnnual Review of Immunology, 2013
- Schistosome-derived omega-1 drives Th2 polarization by suppressing protein synthesis following internalization by the mannose receptorJournal of Experimental Medicine, 2012
- Macrophage activation governs schistosomiasis‐induced inflammation and fibrosisEuropean Journal of Immunology, 2011
- Changes in the mucosal barrier during acute and chronic Trichuris muris infectionParasite Immunology, 2010
- Rapid induction of IgE responses to a worm cysteine protease during murine pre-patent schistosome infectionBMC Immunology, 2010
- CD11c depletion severely disrupts Th2 induction and development in vivoJournal of Experimental Medicine, 2010
- Functional Impairment of Human Myeloid Dendritic Cells during Schistosoma haematobium InfectionPLOS Neglected Tropical Diseases, 2010
- The Schistosoma mansoni Protein Sm16/SmSLP/SmSPO-1 Assembles into a Nine-Subunit Oligomer with Potential To Inhibit Toll-Like Receptor SignalingInfection and Immunity, 2009
- Invariant and Noninvariant Natural Killer T Cells Exert Opposite Regulatory Functions on the Immune Response during Murine SchistosomiasisInfection and Immunity, 2007
- The immunobiology of schistosomiasisNature Reviews Immunology, 2002